{"id":72708,"date":"2012-03-31T01:13:21","date_gmt":"2012-03-31T01:13:21","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/qa-ge-healthcares-mark-dente-on-the-challenges-of-integrating-genomics-data-with-emrs.php"},"modified":"2024-08-17T16:23:16","modified_gmt":"2024-08-17T20:23:16","slug":"qa-ge-healthcares-mark-dente-on-the-challenges-of-integrating-genomics-data-with-emrs","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/qa-ge-healthcares-mark-dente-on-the-challenges-of-integrating-genomics-data-with-emrs.php","title":{"rendered":"Q&amp;A: GE Healthcare&#39;s Mark Dente on the Challenges of Integrating Genomics Data with EMRs"},"content":{"rendered":"<p><p>    GE Healthcare has taken initial steps to    integrate 'omics data into its Centricity electronic medical    record system through an exploratory research project that is    developing a genomics data analysis infrastructure.  <\/p>\n<p>    Mark Dente, GE healthcare's chief medical officer for    healthcare information technology, discussed the project last    week during a panel discussion at the American Medical    Informatics Association's Translational Bioinformatics    conference in San Francisco.  <\/p>\n<p>    The panel discussed several projects that are looking to    integrate genomics data into EMRs. In addition to Dente, panel    participants included representatives from the Electronic    Medical Records and Genomics Network, the Pharmacogenomics    Research Network, and the HL7 clinical genomics workgroup.  <\/p>\n<p>    BioInform spoke to Dente after the conference to get    additional details about GE Healthcare's genomics    infrastructure development plans. The following is an edited    version of that conversation.  <\/p>\n<p>    During your presentation at AMIA, you mentioned that GE    Healthcare is developing a genomics analysis infrastructure.    Could you provide some more details about what you hope to    develop and where those efforts currently stand?  <\/p>\n<p>    What we presented at AMIA was a mix of our technologies that we    have today like our EMR and our ability to have large datasets    to do research against. [T]he genomics effort is where we are    headed, [but] it is not a product [now and] it may never become    a product.  <\/p>\n<p>    What we are talking about here is the driving of personalized    medicine and translational medicine. I am a biomedical,    clinical informaticist ... and my claim to fame is to think    about knowledge management and clinical decision support and    how we can shorten the ... bench-to-bedside timeline, [which]    is about 17 years for something to go from research to full    adoption in clinical practice. Now you compound that with a    part of medicine that most clinicians in clinical practice are    [unfamiliar with]. They learn a little bit of genomics in    undergraduate school [and] in medical school but how do you    educate folks as to ... where the research is going? Finally,    how do we deal with new knowledge repositories in medicine?  <\/p>\n<p>    A lot of our industry is run on old technology. We've made a    large investment on the technology side looking at    services-oriented-architecture. We can put legacy systems ...    and new technology into this new infrastructure and because is    platform we can aggregate data across the institution and even    across the community and do analytics on this data in our data    warehouse.... this SOA architecture is a modern way of doing    that. [We have a] joint venture [with] Microsoft [called    Caradigm that is] focused around that and advanced clinical    decision support.  <\/p>\n<p>    The final leg is [the] genomics platform itself  One thing    around genomics is that there needs to be a higher expectation    on the technology's ability to handle large datasets. An SOA    infrastructure allows us to be more flexible on the technical    side of dealing with genomic information. [Also,] you really    want to think about a genomic repository external to the EMR.    That is my personal approach and how I will strongly suggest    that we as GE will approach this. You do not want to clog up    your operational EMR database with genetic data because it's    just too large. [Also, because] its genetic data, we need to    have a higher expectation of security. We have rigorous HIPAA    and other internal standards of how we manage and keep private    patient information and that will get ratcheted up in the    future.  <\/p>\n<p>    As you start to put data into a genomics database, we need to    marry up the genomic data with the phenotypical data coming off    an EMR. The real exciting part [is] we can start looking at the    genomic data coupled with the phenotypical data in and a    genomic analytic engine concept. With a analytics engine and    the creation of algorisms to look for signal how do we start to    think about running very targeted studies and [looking] for    signals that suggest that these four hypothetical genes, [for    example,] could be predictive of a [disease] state?  <\/p>\n<\/p>\n<p>More:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.genomeweb.com\/informatics\/qa-ge-healthcares-mark-dente-challenges-integrating-genomics-data-emrs\" title=\"Q&amp;A: GE Healthcare&#39;s Mark Dente on the Challenges of Integrating Genomics Data with EMRs\" rel=\"noopener\">Q&amp;A: GE Healthcare&#39;s Mark Dente on the Challenges of Integrating Genomics Data with EMRs<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> GE Healthcare has taken initial steps to integrate 'omics data into its Centricity electronic medical record system through an exploratory research project that is developing a genomics data analysis infrastructure. Mark Dente, GE healthcare's chief medical officer for healthcare information technology, discussed the project last week during a panel discussion at the American Medical Informatics Association's Translational Bioinformatics conference in San Francisco. The panel discussed several projects that are looking to integrate genomics data into EMRs.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/qa-ge-healthcares-mark-dente-on-the-challenges-of-integrating-genomics-data-with-emrs.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246862],"tags":[],"class_list":["post-72708","post","type-post","status-publish","format-standard","hentry","category-pharmacogenomics"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/72708"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=72708"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/72708\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=72708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=72708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=72708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}